WYMM Tour: Oxford
20 February 2024, 10:00 - 17:40 GMT - Oxford, United Kingdom
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Tuesday 20th February 2024 in Oxford to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
10:00 – 20:00 hrs GMT | Agenda (subject to change) | |
|---|---|---|
10:00 – 11:00 hrs | Registration, breakfast and networking | |
11:00 – 11:25 hrs | What you're missing matters: Catching the unnoticed | Tonya McSherry, Oxford Nanopore Technologies |
11:25 – 12:00 hrs | Translating Oxford Nanopore Technology whole genome sequencing into clinical practice | Richard Scott and Emma McCargow, Genomics England |
12:00 – 12:30 hrs | Brain tumour classification with nanopore sequencing | Simon Paine, Nottingham University Hospitals NHS Trust |
12:30 – 14:15 hrs | Lunch | |
14:15 – 14:40 hrs | Oxford Nanopore Technologies bioinformatics update | Philipp Rescheneder, Oxford Nanopore Technologies |
14:40 – 15:05 hrs | Integrating short and long read RNA sequencing to study the human heart at single cell resolution | James Cranley, Teichmann Group, Sanger Institute |
15:05– 15:30 hrs | Present opportunities and challenges for genome-based diagnostics | Tim Aitman, University of Edinburgh |
15:30– 16:30 hrs | Networking session | |
16:30 – 17:00 hrs | Panel discussion: The future of nanopore sequencing in clinical research | Moderated by Chris Swagell, Oxford Nanopore Technologies |
17:00 – 17:30 hrs | Evaluating the diagnostic potential of long reads for rare genetic diseases | Stephan Ossowski, University of Tübingen |
17:30 – 17:40 hrs | Closing remarks | Oxford Nanopore Technologies |
17:40 – 20:00 hrs | Drinks reception |
Speakers
)
Richard Scott, CEO, Genomics England
Dr Richard Scott joined the organisation in 2015. He is also a Consultant and Honorary Senior Lectur...
)
Emma McCargow, Programme Lead, Cancer 2.0, Genomics England
...
)
Brain tumour classification with nanopore sequencing
Simon Paine, University of Nottingham
Simon is a Consultant Neuropathologist in Nottingham, UK. He is fortunate to work with a range of fa...
)
Present opportunities and challenges for genome-based diagnostics
Tim Aitman, University of Edinburgh
Professor Tim Aitman is Director of the Centre for Genomic and Experimental Medicine and Professor o...
)
Integrating short and long read RNA sequencing to study the human heart at single cell resolution
James Cranley, Sanger Institute
...
)
Evaluating the Diagnostic Potential of Long Reads for Rare Genetic Diseases
Stephan Ossowski, University of Tübingen
Stephan Ossowski is professor for Genome Informatics at the University of Tübingen and vice directo...